Ningbo No. 1 Hospital clinical trials
Ningbo No. 1 Hospital is the lead sponsor of 8 current clinical trials in our China register. 3 are recruiting patients now. The most common phase is Not applicable. The most-studied condition is Metabolic Dysfunction-Associated Steatotic Liver Disease.
ClinicalTrials.gov trials by status
Trials by phase
Clinical trials sponsored by Ningbo No. 1 Hospital
8 on ClinicalTrials.gov| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
Accelerated Biological Aging is Associated With Increased Risk of T2DM in the MASLD Population
NCT06984510 · ClinicalTrials.gov ↗ · Type 2 Diabetes Mellitus (T2DM), Metabolic Dysfunction-Associated Steatotic Liver Disease, Biological Age
|
Observational | Recruiting | 2025-04 | China |
|
CD19 CAR-T Expressing IL-7 and CCL19 Combined With Anti-PD1 in RR-DLBCL
NCT05659628 · ClinicalTrials.gov ↗ · Diffuse Large B-cell Lymphoma
|
Phase 1 | Recruiting | 2022-12 | China |
|
Comparing Different Diameter fURSs With Similar RESDs for the Treatment of Upper Urinary Tract Stones
NCT06987760 · ClinicalTrials.gov ↗ · Ureter Injury, Urolithiasis; Lower Urinary Tract, Efficacy, Self
|
Not applicable | Recruiting | 2025-03 | China |
|
Pre-procedural Risk Score-Based Endoscopist Assignment for Pain Reduction in Unsedated Colonoscopy
NCT07713953 · ClinicalTrials.gov ↗ · Colonoscopy Pain
|
Not applicable | Not yet open | 2026-07 | China |
|
Metabolically Healthy Obesity Increases the Risks of MASLD and Hyperuricemia
NCT07001865 · ClinicalTrials.gov ↗ · Metabolic Dysfunction-Associated Steatotic Liver Disease, Metabolically Healthy Obesity, Hyperuricemia
|
Observational | By invitation | 2025-04 | China |
|
Healthy Weight Management Project for Overweight and Obesity Children
NCT05482191 · ClinicalTrials.gov ↗ · Obesity
|
Not applicable | Active, closed | 2022-09 | China |
|
Screening and Intervention of MASLD in Children
NCT06905795 · ClinicalTrials.gov ↗ · MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease, Children
|
Not applicable | Active, closed | 2025-04 | China |
|
Optimizing Intervention Effects in Children and Adolescents
NCT05482165 · ClinicalTrials.gov ↗ · Childhood Obesity
|
Not applicable | Active, closed | 2022-09 | China |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
Conditions in Ningbo No. 1 Hospital trials
14 conditionsBy trial register
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in China | 8 | 3 |
A trial with sites in more than one country appears in each of those registers.
Other sponsors in Metabolic Dysfunction-Associated Steatotic Liver Disease
| Sponsor | Trials |
|---|---|
| Kayseri City Hospital | 2 |
Sponsors with the most current trials registered for this condition.
Questions about Ningbo No. 1 Hospital trials
How many clinical trials does Ningbo No. 1 Hospital sponsor?
Ningbo No. 1 Hospital is the lead sponsor of 8 current trials on ClinicalTrials.gov in our China register, as of the registry sync on 10 November 2026. Completed and withdrawn studies are not counted.
Are Ningbo No. 1 Hospital trials recruiting?
Yes. 3 of its 8 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Where does this information come from?
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
How this page is built
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
- EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 10 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.